Alaunos Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Alaunos Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Alaunos Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.13M, a 87.1% increase year-over-year.
  • Alaunos Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$19.1M, a 48.1% increase year-over-year.
  • Alaunos Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$35.1M, a 6.87% increase from 2022.
  • Alaunos Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$37.7M, a 52.1% increase from 2021.
  • Alaunos Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$78.8M, a 1.53% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$19.1M -$1.13M +$7.64M +87.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$26.8M -$1.68M +$8.37M +83.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$35.1M -$7.84M +$1.32M +14.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$36.5M -$8.48M +$375K +4.24% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$36.8M -$8.77M +$1.16M +11.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$38M -$10M -$260K -2.66% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$37.7M -$9.16M +$2.64M +22.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$40.4M -$8.85M +$13.9M +61.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$54.2M -$9.93M +$12.7M +56.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$67M -$9.79M +$11.8M +54.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$78.8M -$11.8M +$11M +48.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$89.7M -$22.7M -$2.42M -11.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$87.3M -$22.7M -$4.07M -21.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$83.2M -$21.6M -$3.26M -17.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$80M -$22.8M -$7.03M -44.6% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$73M -$20.3M +$53.7M +72.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$127M -$18.6M -$3.98M -27.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$123M -$18.3M -$4.86M -36.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$118M -$15.7M -$210M -108% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $92.5M -$74M -$55.3M -297% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 $148M -$14.6M +$2.87M +16.4% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 $145M -$13.4M +$7.71M +36.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 $137M $195M +$213M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$75.6M -$18.7M -$1.06M -5.99% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$74.5M -$17.5M +$234K +1.32% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$74.7M -$21.1M -$1.48M -7.54% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$73.3M -$18.3M -$3.52M -23.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-05
Q3 2017 -$69.7M -$17.6M -$3.16M -21.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-05
Q2 2017 -$66.6M -$17.7M +$113M +86.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-05
Q1 2017 -$180M -$19.7M -$7.64M -63.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-05
Q4 2016 -$172M -$14.8M -$5.28M -55.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$167M -$14.4M +$3.73M +20.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$171M -$131M -$117M -823% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$53.9M -$12M +$66.2M +84.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$120M -$9.48M +$925K +8.89% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-16
Q3 2015 -$121M -$18.2M -$12.1M -198% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-16
Q2 2015 -$109M -$14.2M -$8.64M -155% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-16
Q1 2015 -$100M -$78.2M -$68.5M -706% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-16
Q4 2014 -$31.8M -$10.4M -$1.5M -16.8% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-24
Q3 2014 -$30.3M -$6.09M +$10.6M +63.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-24
Q2 2014 -$40.9M -$5.58M +$13.1M +70.2% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-24
Q1 2014 -$54M -$9.71M +$3.09M +24.1% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-24
Q4 2013 -$57.1M -$8.9M +$21.3M +70.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-26
Q3 2013 -$78.4M -$16.7M +$1.11M +6.23% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-26
Q2 2013 -$79.5M -$18.7M +$4.92M +20.8% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-26
Q1 2013 -$84.5M -$12.8M +$11.7M +47.7% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-26
Q4 2012 -$96.1M -$30.2M -$17M -128% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-03
Q3 2012 -$79.2M -$17.8M -$17M -2122% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-03
Q2 2012 -$62.1M -$23.6M -$12.9M -120% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-03
Q1 2012 -$49.2M -$24.5M +$14.5M +37.3% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-03
Q4 2011 -$63.8M -$13.2M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$802K +$11.4M +93.4% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 -$10.7M -$19.8M -219% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 -$39M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 -$12.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 $9.04M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.